RE:RE:RE:RE:Softening up for a stink bid?Another amateure comment from a representative of the armchair quarterbacks club! ... lolll Another one into plot theories, another one "
that knows how it works"! ... ;-)
CainPlap thinks that Dr. Kulkarni should have devoted all its time to only one clinical trial! Wow!
Should Dr. Jewett also have done the same? And all these other MDs in all their different practices over teh last 40 years? Science would not have moved quickly!
Top academic institutions like UHN/PMCC do something like 300 clinical trials/year. And there are rules/processes in place to have drugs advanced to avoid such plot theories, in order to benefit patients. CAinPlap talks like if Trump was heading the Ph. 2 consortium!
Funny, I see this as an advantage of having Dr. Kulkarni being in a position to compare TLT technology to Keytruda. Because data is the best way to compare one versus another.
Dr. Jewett mentioned it; even in Ph. 2 there could be room for adjustments, as more patients allow for more data, so more understanding. We call this a learning curve. A simple concept that plot theorists don't understand. No wonder why their HCQ plot was debunked easily.
____________
CAinPlap - (10/30/2020 3:09:40 PM) RE:RE:RE:Softening up for a stink bid? Hachet or Hachey job? ;)
To be fair, doubt trial "misstake" was her fault. It is Dr. K's loyalty we need to question given his involvement with much larger, deeper pocketed companies.